Internist

Λεωφόρος Κηφισίας 5, Ampelokipoi, Attica

Next availability
Check availability

Why he is suitable for you

Konstantinos Mpalampanis MD, PhD is an Internal Medicine Physician - Diabetologist with private practices in Piraeus, Salamina, and Athens. He holds a doctorate from the Medical School of the University of Patras and earned his medical degree from the same university. He is certified in BLS/AED (Basic Life Support) and ILS/AED (Immediate Life Support) by the European Resuscitation Council. He completed his specialty training in Internal Medicine at the 2nd Propaedeutic Internal Medicine Clinic of the University of Athens and has since served as a University Research Fellow in Internal Medicine - Diabetes Mellitus & Obesity at the 2nd Propaedeutic Internal Medicine Clinic of the University of Athens and the Research Unit of the Attikon University Hospital. Since 2013, as part of his tenure at the 2nd Propaedeutic Clinic of the University of Athens - Diabetes Center, he has been actively involved daily in the activities of the Diabetes Clinic of the 2nd Propaedeutic Internal Medicine Clinic. He has participated as a Sub-Investigator in over 18 multicenter studies (phase 2 & 3) focusing on Diabetes Mellitus, Obesity, Fatty Liver Disease, and Lipodystrophies. This activity continues to the present. He has a substantial research and teaching portfolio and has participated in conferences and seminars both in Greece and internationally. Finally, it is worth noting that his private practice offers, among other services, specialized diabetes, pre-diabetes, and obesity screening, as well as dietary services (through collaboration with Dietitians - Nutritionists), always fully understanding the specific needs of each patient.

The description was edited by the doctoranytime team, based on verified information.

Experience

Relative Experience

  • Diabetology
  • Metabolic diseases

Ακαδημαϊκός Υπότροφος Παθολογίας - Σακχαρώδους Διαβήτη (7 τελευταία έτη) στην Β΄ Πανεπιστημιακή Κλινική του Πανεπιστημιακού Γενικού Νοσοκομείου Αθηνών "Αττικόν".

6 patients' recommendations

Relative Studies

Διδακτορικός τίτλος με αντικείμενο τον Σακχαρώδη Διαβήτη και την Παχυσαρκία από το Πανεπιστήμιο Πατρών. Πολυκεντρικές Μελέτες σταδίου ΙΙ & ΙΙΙ με αντικείμενο τον Σακχαρώδη Διαβάτη, την Παχυσαρκία, το Λιπώδες Ήπαρ (NAFLD), Λιποδυστροφίες.

Patient Reviews

10
From 6 reviews

Real reviews for real people

Investigated my case in depth
10
Trustworthy
10
Experienced & qualified
10
Punctual
10
Approachable & friendly
10

Reviews are written by people who had an appointment with a specialist and want to share their experience. Learn how we ensure their authenticity

  • All (6)
  • Positive (6)
  • Neutral (0)
  • Negative (0)

10.0
Παναγιώτης • 1 review
Εξαίρετος γιατρός!πήγε ο σύζυγος και έμεινε πολύ ικανοποιημένος!!θα ξανά πάμε σίγουρα!!το συνιστώ ανεπιφύλακτα
08 March 2023

10.0
Ηρώ • 10 reviews
Κατατοπιστικός, επεξηγηματικός και με άριστη κατάρτιση και συμπεριφορά . Επιστήμονας με ανθρωπιστική προσέγγιση που εξετάζει σε βάθος τον ασθενή .
15 September 2021

10.0
ΓΕΩΡΓΙΟΣ • 1 review
Πολύ φιλικός, σε κάνει να νιώθεις άνετα και οικεία, είναι απόλυτα εξειδικευμένος στο αντικείμενό του και το δείχνει.
08 September 2021

10.0
ΠΑΝΑΓΙΩΤΗΣ • 4 reviews
Ολα ηταν οπως επρεπε!
27 June 2019

10.0
Vagia • 1 review
Πολύ καλός ο γιατρός όλα μια χαρά
10 October 2018

10.0
Μιχάλης • 1 review
Δείχνει εξαιρετικά καταρτισμένος επιστήμονας και είναι πολύ φιλικός
02 March 2018

Contact and location

    • Address
      Λεωφόρος Κηφισίας 5, Ampelokipoi, Attica
    • Metro
      • 360m ΑΜΠΕΛΟΚΗΠΟΙ
      • 680m ΠΑΝΟΡΜΟΥ
      • 1,19km ΜΕΓΑΡΟ ΜΟΥΣΙΚΗΣ
    • Bus
      • 120m ΑΜΠΕΛΟΚΗΠΟΙ
      • 170m ΑΘΗΝΑΙΟΝ
      • 240m ΓΑΛΑΞΙΑΣ
    • Parking
      • Easy parking
Could not find any practice in map.

Payment Methods

  • Payment Methods

    • Bank Card
    • Cash

    Appointment Policy

    • Payment at the practice

      During your visit, you can select the payment method of your choice from the options mentioned above.

    • Cancellation

      You can always cancel up to 3 hours before the appointment. For more information please read our cancellation policy.

Curriculum Vitae and Career

Studies

  • PhD, Faculty of Medicine, thesis entitled: "Inter-tissue expression patterns of key metabolic biomarkers in patients with clinically severe obesity. Impact on obesity-induced disease," University of Patras
  • Acquisition of medical specialty title in Pathology (20/02/2013)
  • Degree, School of Health Sciences, Faculty of Medicine, University of Patras
  • Certification BLS/AED Provider Course (Basic Life Support), European Resuscitation Council
  • Certification ILS/AED Provider Course (Immediate Life Support), European Resuscitation Council
  • Graduated from Arsakeio-Tositsio High School of Ekali

Professional experience

  • Private medical practice at the MEDIPOLIS health complex, Piraeus
  • Private medical practice, Athens
  • University Pathology - Diabetes Fellowship, 2nd Propaedeutic Pathology Clinic of the University of Athens - Research Unit, "Attikon" University General Hospital, (03/28/2014 - present)
  • Department of Clinical Studies - Research Protocols on Diabetes Mellitus - Dyslipidemia, 2nd Propaedeutic Pathology Clinic of the University of Athens - Research Unit, "Attikon" University General Hospital
  • Scientific Collaborator, 6th Cardiology Clinic, "HYGEIA" Hospital
  • Medical Educator CVRM, AstraZeneca, (04/08/2019 - present)
  • Member of the scientific cardio-metabolic team "The Heart Team"
  • Consultant Physician, Scientific Head of the Diabetes Clinic, 3rd Pathology Clinic, "Errikos Dynan" Hospital
  • On-call Physician, Pathology Clinic, General Hospital of Aigio
  • External Collaborator, Prevent Hellas, Prevention Health Concepts
  • Medical Collaborator, Specialized Pathology Clinic Kanakidis E.P.E.
  • Physician, professional football tournament "Kostas Davourlis" O.N.A.P., (2005 & 2006)
  • Physician, football league of E.P.S. Achaia, (seasons 2004 - 2005 & 2005 - 2006)
  • Acquisition of medical specialty title in Special Pathology, (02/20/2013)
  • Extension of specialty training period, (09/19/2012 - 09/19/2013)
  • Specialist Trainee, 2nd Propaedeutic University Pathology Clinic of the University of Athens, "Attikon" University General Hospital, (03/2007 - 09/2012)

Participation in conferences

  • ΣΥΜΜΕΤΟΧΗ ΣΕ ΕΡΕΥΝΗΤΙΚΑ ΠΡΩΤΟΚΟΛΛΑ (ως SUB-investigator)
  • 1. Describing the Actual Type 2 Diabetes Response Strategy in Day Clinical Practice in Greece: DETECT STUDY
  • 2. BAY-94-8862/16244 - A randomized, double-blind, placebo-controlled, parallel-group, multicenter, event-driven Phase III study to investigate the efficacy and safety of finerenone, in addition to standard of care, on the progression of kidney disease in subjects with type 2 diabetes mellitus and the clinical diagnosis of diabetic kidney disease
  • 3. A randomized, double-blind, placebo-controlled, parallel-group, multicenter, event-driven Phase III study to investigate the efficacy and safety of finerenone on the reductionof cardiovascular morbidity an mortality in subjects with type 2 diabetes mellitus and theclinical diagnosis of diabetic kidney disease in addition to standard of care.
  • 4. A Long Term, Randomised, Double Blind, Placebo-controlled Study to Determine the Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Patients With Type 2 Diabetes Mellitus
  • 5. A Randomized, Double-Blind, Placebo-Controlled, with an Open Label Extension, Phase 2/3 Study of ISIS 304801 Administered Subcutaneously to Patients with Familial Partial Lipodystrophy
  • 6. A randomised, double blind, placebo-controlled study of the effect of liraglutide on arterial blood pressure in hypertensive patients with type 2 diabetes mellitus
  • 7. Effect and safety of semaglutide 2.4 mg once-weekly in subjects with overweight or obesity and type 2 diabetes
  • 8.Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity (SELECT) diab EX9536-4388
  • 9. “A multi-center open-label parallel group randomized controlled trial to compare* iGlarLixi versus premixed insulin * in patients with type 2 diabetes who have failed to
  • achieve glycemic control with basal insulin and oral antidiabetic agents” ongoing (SANOFI )
  • 10. TAKE CONTROL: A 24-Week, Multicentre, Randomized, Open-Label, 2-Arm Parallel-group study evaluating the Efficacy and Safety of Patient-versus Physician- managed Titration of Insulin Glargine U300 in Type 2 Diabetes Mellitus (LPS14409)
  • 11. Non-interventional, Multicenter Clinical Trial to Investigate the Efficacy of Rosuvastatin in Patients With Hyperlipidemia and Other Cardiovascular Risk Factors
  • 12. του έργου Τ1ΕΔΚ-05722, ακρωνύμιο «ACB-Gel» και τίτλο «Παραγωγή, διάθεση και εφαρμογή προϊόντος γέλης (gel) αιμοπεταλίων από ομφαλοπλακουντιακό αίμα σε ασθενείς με διαβητικό πόδι» Πρόγραμμα υλοποίησης συνεργατικών ερευνητικών έργων στο πλαίσιο της Δράσης «ΕΡΕΥΝΩ –ΔΗΜΙΟΥΡΓΩ - ΚΑΙΝΟΤΟΜΩ» (ΕΣΠΑ 2014-2020) Έναρξη 17/10/2018 έως 17/10/2020
  • ΟΜΙΛΙΕΣ ΣΕ ΣΥΝΕΔΡΙΑ ( ΜΕ ΑΝΤΙΚΕΙΜΕΝΟ ΤΟΝ ΣΑΚΧΑΡΩΔΗ ΔΙΑΒΗΤΗ)
  • 1. Δυσλιπιδαιμία στον Σακχαρώδη Διαβήτη τύπου 2. Η θέση των νεότερων παραγόντων Congress Highlights 2016 . Ελληνική Διαβητολογική εταιρεία
  • 2. Αντιδιαβητική αγωγή με αναστολείς DPP4. Ιδιαίτερα χαρακτηριστικά και ιδιότητες της Λιναγλιπτίνης Πανελλήνιο Συνέδριο Γενικής Ιατρικής (06/05/2016 , Ρόδος )
  • 3. Ο Διαβητικός ασθενής στο χειρουργείο προετοιμασία : Η πλευρά του διαβητολόγου Νοσοκομείο Ερρίκος Ντυνάν (02/04/2016, Αθήνα )
  • 4. Θεραπεία Διαβητικών Ασθενών με χρήση Ινσουλίνης Νοσοκομείο Ερρίκος Ντυνάν (23/03/2016, Αθήνα )
  • 5. Προ εγχειρητική & μετεγχειρητική ρύθμιση του ασθενούς με Σακχ. διαβήτη Νοσοκομείο Ερρίκος Ντυνάν (01/10/2016, Αθήνα)
  • 6. Θεωρία και πράξη στην Χρήση των SGLT-2 αναστολέων Αράχοβα 2017
  • 7. Ο ρόλος της λιναγλιπτίνης στην αντιμετώπιση του σακχαρώδη διαβήτη τύπου 2 Βυτίνα 03/10/2015
  • 8. Το Μέλλον Στην Ινσουλινοθεραπεία Ηράκλειο Κρήτης 06/2015. Μετεκπαιδευτικά μαθήματα Ινσουλινοθεραπείας ΕΔΕ
  • 9. Σακχαρώδης Διαβήτης Τύπου 2 & Καρδιαγγειακή Νόσος : Ο Ρόλος της Εμπαγλιφλοζίνης στην σύγχρονη θεραπευτική προσέγγιση 17ης Επιστημονική Εκδήλωση ΕΚΟΜΕΝ, 2 -5 Ιουνίου 2017, Κεφαλονιά
  • 10. Έναρξη Ινσουλινοθεραπείας με γλαργινική Ινσουλίνη. Αξιοποιώντας το gold standard της βασικής Ινσουλινοθεραπείας έγκαιρα και αποτελεσματικά 2ο Σχολείο Θεραπευτικής για τα Καρδιομεταβολικά Νοσήματα (13-15/10/2017, Ναύπλιο)
  • 11. Σακχαρώδη Διαβήτη Τύπου 1. Εναλλακτικές Θεραπείες Εκτός Της Ινσουλίνης «Σακχαρώδης Διαβήτης. Η παθολογία συνεργάζεται και περιποιεί το διαβήτη. Νεότερες θεραπευτικές θεωρήσεις στην καθημερινή κλινική πρακτική και στην πρόληψη των επιπλοκών” της Ελληνικής Εταιρίας Κλινικής Διατροφής και
  • Μεταβολισμού σε συνεργασία με το Metropolitan General, Παθολογική – Διαβητολογική Κλινική & Διαβητολογικό Κέντρο. Αθήνα 23 & 24 Νοεμβρίου 2018
  • 12. Ενέσιμη αγωγή με GLP-1 ανάλογα (Νεότερα δεδομένα από ADA & EASD 2018) Congress Highlights 24 Νοεμβρίου 2018 . Ελληνική Διαβητολογική εταιρεία
  • 13. «Παχυσαρκία και άλλοι παράγοντες καρδιαγγειακού κινδύνου στο ΣΔτ2. Οι επιδράσεις της Εμπαγλιφλοζίνης και η μείωση της καρδιαγγειακής Θνησιμότητας». 13ου Πανελληνίου Ιατρικού Συνεδρίου Παχυσαρκίας. Αθήνα

Spoken languages

  • English

Academic research and publications

  • Παθογένεια και αντιμετώπιση της αρτηριακής υπέρτασης στο σακχαρώδη διαβήτη, Κ.Π Μπαλαμπάνης, Α.Ε Ράπτης, «Στρατηγικές στο Σακχαρώδη Διαβήτη 2014»
  • ΔΗΜΟΣΙΕΥΣΕΙΣ ΜΕ ΑΝΤΙΚΕΙΜΕΝΟ ΤΟΝ ΣΑΚΧΑΡΩΣΗ ΔΟΑΒΗΤΗ ΚΑΙ ΤΟΝ ΜΕΤΑΒΟΛΙΣΜΟ
  • 1. Inter-tissue expression patterns of the key metabolic biomarker PGC-1α in severely obese individuals: Implication in obesity-induced disease. Balampanis K, et al. Hellenic J Cardiol. 2018 Aug 20. pii: S1109-9666(18)30252-5.
  • 2. Can obesity-induced inflammation in skeletal muscle and intramuscular adipose tissue accurately detect liver fibrosis? Chasapi A, Balampanis K et al J Musculoskelet Neuronal Interact. 2018 Dec 1;18(4):509-524.
  • 3. SRC-3/AIB-1 Enhances Hepatic NFATC1 Transcription and Mediates Inflammation in a Tissue-Specific Manner in Morbid Obesity. Chasapi A, Balampanis K, Tanoglidi A, Kourea E, Lambrou GI, Lambadiari V, Kalfarentzos F, Hatziagelaki E, Melachrinou M, Sotiropoulou-Bonikou G. Endocr Metab Immune Disord Drug Targets. 2019 Jul 15.
  • 4. Effects of Different Antidiabetic Medications on Endothelial Glycocalyx, Myocardial Function, and Vascular Function in Type 2 Diabetic Patients: One Year Follow-Up Study. Lambadiari V, Pavlidis G, Kousathana F, Maratou E, Georgiou D, Andreadou I, Kountouri A, Varoudi M, Balampanis K, Parissis J, Triantafyllidi H, Katogiannis K, Birba D, Lekakis J, Dimitriadis G, Ikonomidis I. J Clin Med. 2019 Jul 5;8(7). pii: E983.

Articles

Doctoranytime is an end-to-end solution that assists the user from the moment they experience a health symptom until the moment it is resolved, by enabling them to find the specialist they need, request guidance via chat and talk to them via video call. The information provided has been filled in by Mpalampanis Konstantinos and edited by the doctoranytime team.
Log in or register to continue
Log in or register to continue

Continue with

or register with your email address

The password should contain at least 6 characters and 1 capital letter
Create a new password

Enter the email you used to register in doctoranytime and we'll send you a link to create new password

Your data is in good hands
doctor-graphic doctor-graphic

doctoranytime takes your health as well as your data protection very seriously!

In order to ensure you that:

  • you will continue to get the best possible treatment from the affiliated doctors and diagnostic centers
  • you will continue to book your appointments easily and quickly by having at the same time the right of evaluation
  • we will be able to contact you immediately in case of a change in your appointment
  • you will continue to receive our newsletter and health suggestions that may interest you

it is essential for us to collect and process your personal data to the extent that you allow.

For this reason, we would like to inform you that we take all the necessary measures in order to protect your personal data, according to the New European General Data Protection Regulation (“GDPR”), the terms of the doctoranytime Privacy Policy (that you can read in detail here) and the law requirements.

If you have any questions regarding your privacy protection by doctoranytime or in case you wish to exercise your GDPR rights (information, access, correction, deletion, limitation of processing, portability of your data, objection and right to lodge a complaint with the Personal Data Protection Authority) you can contact the Data Protection Officer of doctoranytime on: [email protected].

Terms of Use

Congratulations!!

Your registration has completed.